Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 2, 2017
Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical DonorMalgorzata Mikulska, Anna Maria Raiola, Federica Galaverna, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 10, 2014
Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling graftsAnna Maria Raiola, Alida Dominietto, Carmen di Grazia, et al.
The Pediatric Infectious Disease Journal|March 12, 2021
Prophylaxis With Trimethoprim/Sulfamethoxazole Is Not Necessary in Children With Solid Tumors Treated With Low-medium Intensity ChemotherapyCristina Meazza, Federica Galaverna, Maria Grazia Petris, et al.
Frontiers in Immunology|June 2, 2020
Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute LeukemiaPietro Merli, Mattia Algeri, Federica Galaverna, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2015
Improved Outcome of Alternative Donor Transplantations in Patients with Myelofibrosis: From Unrelated to Haploidentical Family DonorsStefania Bregante, Alida Dominietto, Anna Ghiso, et al.
Italian Journal of Pediatrics|November 26, 2025
Recommendations for antibacterial prophylaxis in children receiving chemotherapy: a joint initiative of SITIP and infectious disease group of AIEOPDaniele Zama, Davide Leardini, Francesco Baccelli, et al.
Blood Advances|December 17, 2021
The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantationElisabetta Metafuni, Irene Maria Cavattoni, Teresa Lamparelli, et al.
Current Drug Targets|January 27, 2015
Cardioprotection by Targeting the Pool of Resident and Extracardiac ProgenitorsKonrad Urbanek, Caterina Frati, Gallia Graiani, et al.
Pharmacological Research|October 2, 2017
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitorsMonia Savi, Caterina Frati, Stefano Cavalli, et al.
Frontiers in Oncology|January 23, 2024
Case report: A safeguard in the sea of variants of uncertain significance: a case study on child with high risk neuroblastoma and acute myeloid leukemiaFrancesco Fabozzi, Rosalba Carrozzo, Mariachiara Lodi, et al.
Pageof 5